Assura (LON:AGR) Trading 14.3% Higher - Here's What Happened
Assura Plc's stock surged 14.3% on Monday, reaching a high of GBX 46.86 ($0.60) before closing at GBX 46.56 ($0.60). Trading volume increased by 256% to 78,156,086 shares. The company has a market cap of £1.52 billion and a debt-to-equity ratio of 85.05. Assura, a healthcare property investor, operates over 600 healthcare buildings in the UK and Ireland and achieved B Corp certification in July 2024, becoming the first FTSE 250 company to do so.
Assura Plc (LON:AGR - Get Free Report)'s stock price shot up 14.3% on Monday . The company traded as high as GBX 46.86 ($0.60) and last traded at GBX 46.56 ($0.60). 78,156,086 shares changed hands during mid-day trading, an increase of 256% from the average session volume of 21,937,410 shares. The stock had previously closed at GBX 40.74 ($0.52).
Assura Trading Up 14.3 %
The company has a debt-to-equity ratio of 85.05, a current ratio of 0.89 and a quick ratio of 2.84. The stock's 50-day moving average is GBX 38.87 and its two-hundred day moving average is GBX 39.81. The company has a market cap of £1.52 billion, a P/E ratio of -44.51, a P/E/G ratio of 3.60 and a beta of 0.37.
About Assura
(Get Free Report)Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served. We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G). Assura plc achieved B Corp certification in July 2024 - the first FTSE 250 business to do so.
See Also
- Five stocks we like better than Assura
- Consumer Staples Stocks, Explained
- How to Protect Your Portfolio When Inflation Is Rising
- Procter & Gamble NYSE: PG Pulls Back After Shaky Guidance
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- REIT Stocks - Best REIT Stocks to Add to Your Portfolio Today
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Should You Invest $1,000 in Assura Right Now?
Before you consider Assura, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Assura wasn't on the list.
While Assura currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
